An internationally renowned expert in virology, immunology and vaccine development, Dr. Corey’s research focuses on herpes viruses and HIV. Current studies include mucosal immunity of viral infections, spatial and functional characterization of tissue resident immune responses at the site of herpesvirus or HIV infection, and spatial dynamics and function of adoptively transferred or vaccine induced T cells. He is the principal investigator of the HIV Vaccine Trials Network, the international collaboration of scientists devoted to developing a globally effective HIV vaccine. Dr. Corey is also past president and director of Fred Hutchinson Cancer Research Center, and a member of the National Academy of Medicine, and the American Academy of Arts and Sciences. Corey received his medical degree from the University of Michigan and his infectious diseases training at the University of Washington.
Ira Mellman, Genentech
Human cells have been successfully used as treatment for blood cancers for decades but translating the promise to cell-based treatment for solid tumors has been slow. The advent of gene-editing techniques such as CRISPR, coupled with advances in our understanding of immunology and optimization of growing, manufacturing, transporting, storing, and handling specialized biological samples and materials is transforming the cell therapy field. We will hear in this session about some of the most promising work in the field, as well as the challenges in overcoming resistance